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Abstract
Background: Rapid and point-of-care (POC) tests for syphilis are an invaluable screening tool, yet inadequate evaluation of
their diagnostic accuracy against best reference standards limits their widespread global uptake. To fill this gap, a systematic
review and meta-analysis was conducted to evaluate the sensitivity and specificity of rapid and POC tests in blood and
serum samples against Treponema pallidum (TP) specific reference standards.
Methods: Five electronic databases (1980–2012) were searched, data was extracted from 33 articles, and Bayesian
hierarchical models were fit.
Results: In serum samples, against a TP specific reference standard point estimates with 95% credible intervals (CrI) for the
sensitivities of popular tests were: i) Determine, 90.04% (80.45, 95.21), ii) SD Bioline, 87.06% (75.67, 94.50), iii) VisiTect,
85.13% (72.83, 92.57), and iv) Syphicheck, 74.48% (56.85, 88.44), while specificities were: i) Syphicheck, 99.14% (96.37, 100),
ii) Visitect, 96.45% (91.92, 99.29), iii) SD Bioline, 95.85% (89.89, 99.53), and iv) Determine, 94.15% (89.26, 97.66). In whole
blood samples, sensitivities were: i) Determine, 86.32% (77.26, 91.70), ii) SD Bioline, 84.50% (78.81, 92.61), iii) Syphicheck,
74.47% (63.94, 82.13), and iv) VisiTect, 74.26% (53.62, 83.68), while specificities were: i) Syphicheck, 99.58% (98.91, 99.96), ii)
VisiTect, 99.43% (98.22, 99.98), iii) SD Bioline, 97.95%(92.54, 99.33), and iv) Determine, 95.85% (92.42, 97.74).
Conclusions: Rapid and POC treponemal tests reported sensitivity and specificity estimates comparable to laboratory-based
treponemal tests. In resource limited settings, where access to screening is limited and where risk of patients lost to follow
up is high, the introduction of these tests has already been shown to improve access to screening and treatment to prevent
stillbirths and neonatal mortality due to congenital syphilis. Based on the evidence, it is concluded that rapid and POC tests
are useful in resource limited settings with poor access to laboratories or screening for syphilis.
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Introduction
The World Health Organization (WHO) estimated that in
2006, there were approximately 12 million new cases of syphilis
[1], with the highest disease burden in sub-Saharan African and
South and Southeast Asian countries where prenatal screening
rates are often as low as 30% leading to high rates of stillbirths and
congenital syphilis [1]. The Centers for Disease Control and
Prevention (CDC) estimated that approximately 64% cases of
syphilis in the United States of America (USA) were among men
who have sex with men (MSM) [2]. Globally, lack of awareness
concerning one’s serostatus is one of the main driving forces of the
syphilis epidemic as approximately 90% of those infected do not
know they are infected [3]. Estimates of disease burden across
global settings are under-estimated due to lack of regular screening
initiatives for at risk populations, namely sexually transmitted
diseases (STD) clinic attendees, MSM and pregnant women.
Syphilis is diagnosed using laboratory tests, consisting of non-
Treponema pallidum (non-TP) and Treponema pallidum (TP) specific
tests. First line screening is usually performed with non-TP tests
that detect anti-cardiolipin antibodies such as rapid plasma reagin
(RPR) and venereal diseases research laboratory (VDRL) tests that
are popular globally [4]. These tests are cheaper compared to
treponemal tests, but they detect a cardiolipin antigen that also
occurs in many conditions other than syphilis such as auto-
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immune diseases and malaria. Therefore, confirming a prelimi-
nary positive RPR or VDRL with a treponemal specific test that
detects antibodies to Treponema pallidum is necessary [4]. Some
examples of typical treponemal specific tests are Treponema pallidum
haemagglutination assay (TPHA), Treponema pallidum particle
agglutination assay (TPAA) [4], and fluorescent treponemal
antibody absorption (FTA-Abs) [5]. These tests are expensive,
laboratory-based, require a continuous supply of electricity,
reagents and trained staff, and are rarely available outside of
reference laboratories [6]. As a result in many countries, treatment
is based on RPR results leading to over-treatment of biologically
false positive patients.
In recent years, syphilis rapid and point-of-care (POC) tests
which detect antibodies to T. pallidum antigen have become
popular due to their many advantages [6]. In order to define the
ideal characteristics of a rapid and POC test, the WHO Sexually
Transmitted Diseases Diagnostic Initiative (SDI) established the
ASSURED criteria: Affordable, Sensitive, Specific, User-friendly,
Rapid and robust, Equipment free, and Deliverable to those who
need them [5,7,8]. Rapid and POC tests are performed on one
patient at a time with results communicated to the patient within
20 minutes, saving time, preventing loss to follow up and allowing
for same day treatment administration [6]. Rapid and POC tests
thus offer the potential to increase access to screening, offering
opportunities for Same-day Testing and Treatment (STAT) to
prevent stillbirths or transmission of syphilis to the foetus if
performed before the third trimester [1,8]. However, treponemal
antibodies persist for a long time, making it impossible to
distinguish between active and past treated infection. In resource
limited settings where most populations don’t have access to a
laboratory, those who are found to be seropositive by treponemal
rapid and POC tests are treated for syphilis to interrupt potential
transmission to a sexual partner or to the foetus in case of pregnant
women. This is now accepted practice as the risk of over-treatment
due to biological false positives which are not syphilis in origin is
more acceptable than the risk of non-treatment of syphilis.
Despite these advantages, scepticism regarding accuracy of
syphilis rapid and POC tests are an obstacle to widespread uptake.
To date, only one review has evaluated the diagnostic accuracy of
syphilis rapid and POC tests. This review only focused on specific
sub-populations (i.e., antenatal clinic attendees and STD clinic
attendees) [9]. Additionally, authors have avoided a head-to-head
comparison of globally popular tests, and ignored the role of
reference standards in assessing accuracy. A perfect reference
standard for syphilis does not exist [5] and therefore, past data
based on this approach are limited in their accuracy. To fill the
current knowledge gap in accuracy of rapid and POC syphilis
tests, a thorough comparative evaluation of all globally used rapid
and POC tests using serum and blood samples was conducted. A
Bayesian latent class analysis that does not assume availability of a
perfect reference standard was used. This meta-analysis is
important as it includes all global sub populations at risk, thus
generating high quality evidence to inform global policy.
Methods
The PRISMA guidelines were followed in conducting and
reporting this meta-analysis [10].
Search strategy
Five electronic databases (MEDLINE, EMBASE, GLOBAL
HEALTH, BIOSIS, and Web of Science) were searched for the
period of January 1980 to March 2012.
Search string
The search string contained the following keywords: (syphilis
OR Treponema pallidum) AND (Point-of-Care OR rapid test* OR
rapid assay*). Articles reported in all languages and studies
conducted involving human subjects were reviewed and translat-
ed.
Study selection
Two reviewers (Yalda Jafari [YJ] and Sushmita Shivkumar
[SS]) independently conducted the search. A third reviewer,
(Nitika Pant Pai [NPP]), resolved discrepancies. Only studies that
evaluated diagnostic accuracies and reported or allowed extraction
of raw cell values (True Positive [TP], False Positive [FP], True
Negative [TN], and False Negative [FN]) were included. Only
rapid and POC tests that met the ASSURED criteria were
included. Figure 1 depicts the study selection process.
Data collection process
YJ extracted data from all included studies while SS indepen-
dently extracted data from 30% of studies. Authors were contacted
if further information was required.
Data items and summary measures: Information on author,
year, location, population, study design, sample used, index test,
reference test and raw cell values were extracted using a
standardized data collection form. Outcomes were defined as
sensitivity and specificity of the index test.
Risk of bias in individual studies
Critical appraisal was undertaken using quality assessment of
diagnostic accuracy studies (QUADAS) and standards for the
reporting of diagnostic accuracy studies (STARD) respectively.
QUADAS is a 14 item checklist used to evaluate the methodology
of diagnostic studies [11] and STARD is a 25 item checklist used
to evaluate the reporting of diagnostics studies [12].
Synthesis of results
Subgroups were created based on: a) index test, b) type of
sample (serum or whole blood) and c) type of reference standards
(TP specific, non-TP specific, or TP and non-TP specific).
Biologically, results in serum are found to have higher sensitivity
and specificity [9]. Therefore, it was important to consider the
distinction between specimens that were tested. The distinction
between reference tests (i.e., TP, non-TP, or TP and non-TP) was
also considered important because results of each type of reference
standard indicated different biological status and stage of infection.
This assessment impacts the accuracy of the index test as the index
tests are TP specific tests. Figure 2 summarizes the subgroup
stratification strategy.
Statistical analysis
Bayesian Hierarchical Summary Receiver Operating Charac-
teristic Curve (HSROC) models were fit using the HSROC add-
on package (version 2.0.5, Montreal) to R (version 2.12.1, 2010,
The R Foundation for Statistical Computing). The program
calculated overall sensitivities and specificities and estimated the
SROC curve [13]. HSROC uses methods that allow for variability
between index tests, studies, populations, and chance that impact
evaluation of the accuracy of an index test [14]. In particular, it
does not require reference standards to be considered as perfect
indicators of true disease status, and there is a strong advantage of
the latent class model used compared to other approaches. For
reasonable estimation of all parameters, a minimum of four studies
at the lowest stratification level is required.
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Model assumptions
Analyses were carried out assuming a perfect and imperfect
reference standard. When no perfect reference standard is
assumed, the statistical estimation problem becomes non-identifi-
able, meaning in practice that not all parameters can be estimated
without the input of external information. Indeed, when a perfect
reference standard is assumed, the external information is that the
reference standard has 100% sensitivity and specificity. Using the
methods implemented by the HSROC model, one can relax this
almost surely false assumption by putting prior ranges on the likely
values of the true sensitivity and specificity of the reference
standard. For this purpose, prior distributions that were extracted
from the literature were used. All priors were non-informative and
the second level of the hierarchical model grouped the parameters
(sensitivity and specificity) from each study.
Assumptions of accuracy
Peeling et al. [5] reviewed conventional tests such as TPHA and
TPPA and found sensitivities in the range of 85% to 100% and
specificities in the range of 98% to 100%. RPGA, the reference
standard used by Rotanov et al. [15], was classified as a test similar
to TPHA and TPPA, and similar accuracy parameters were used.
FTA-ABS was estimated to have a sensitivity of 70% to 100% and
a specificity of 94% to 100% [5]. For combination TP and non-TP
reference standard, an estimate of range of 90% to 100% for both
sensitivity and specificity were assumed.
Additional sensitivity analysis
The priors used to adjust for imperfect reference standards were
derived from literature, and as such, they were evaluated against
Figure 1. Study selection flow chart as per PRISMA guidelines.
doi:10.1371/journal.pone.0054695.g001
Figure 2. Stratification strategy employed to make subgroups
for pooling.
doi:10.1371/journal.pone.0054695.g002
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other imperfect reference standards. In view of this, a sensitivity
analysis was conducted to determine the effect of priors on the
estimates by widening the prior parameters used under the
imperfect reference standard assumption, by 5%, 10% and 15%
on each end of the range.
Results
Demographic characteristics
A list of included studies and their characteristics are presented
in Table S1 x. Forty-four full text articles were assessed for
eligibility, of which 33 (75%) were included in the meta-analysis.
Some articles evaluated more than one index test, in more than
one sample or more than one population, leading to 131 included
data sets. A total of 58% (197/33) of articles evaluated the rapid
and POC test using whole blood. In this group, 37% (7/19) of
articles tested STD clinic attendees, 26% (5/19) tested female sex
workers (FSW), 47% (9/19) tested antenatal clinic attendees
(ANC) and 5% (1/19) used blood supplied by hospital. All studies
were conducted on adults. In terms of settings, only about 10%
(13/131) of studies were conducted in high-income countries. A
majority (81%; 106/131) used a TP specific reference standard,
17% (22/131) used a combination reference standard and 2% (3/
131) of studies used non-TP reference tests. For the purpose of this
meta-analysis, articles were denoted as using adequate reference
standards if the reference standard identified the same antibody as
the index test.
Characteristics of rapid and POC tests
Through this review, 18 rapid and POC tests in global use were
identified. The vast majority were immuno-chromatographic strip
(ICS) based assays with most tests being Determine (Abbott
Diagnostics, UK) at 29% (38/131), SD Biolines (Standard, South
Korea) at 18% (23/131), Syphicheck (Qualpro, India) at 15% (19/
131) and VisiTect (Omega Diagnostics, UK) at 16% (21/131). A
low number of studies employed non-TP and combination TP and
non-TP reference standards, therefore, only meta-analysis of
results using TP specific reference standard were found to be
meaningful. As well, results of studies using of TP specific
reference standard are biologically most valid as rapid and POC
tests and TP specific reference standards both detect antibodies to
T. palladium antigen.
Meta-analysis output
Results of this meta-analysis are presented in Table 1 and the
summary receiver operating characteristics (SROC) curves under
the imperfect reference standard assumption are presented in
Figures S1, S2, S3, S4, S5, S6, S7, S8, and S9.
In whole blood sample, using a TP specific reference standard,
under the imperfect reference standard assumption, sensitivity and
specificity estimates with 95% credible intervals (CrI) for
Determine was 86.32% (77.26, 91.70) and 95.85% (92.42,
97.74), for SD Bioline was 84.50% (78.81, 92.61) and 97.95%
(92.54, 99.33), for Syphicheck was 74.47% (63.94, 82.13) and
99.58% (98.91, 99.96) and for VisiTect was 74.26% (53.62, 83.68)
and 99.43% (98.22, 99.98).
The results of the sensitivity analysis are presented in Table 2.
Generally, change in priors did not affect the accuracy. Except for
sensitivity of Determine, in whole blood, using combination TP
and non-TP specific reference standard which changed from
around 45% to 77%, none of the changes were statistically
significant.
Quality
Quality of methodology of studies was assessed using the
QUADAS checklist. Results from the QUADAS evaluation of
included articles are summarized in Table S2. There was minimal
potential for incorporation bias (100%), all articles provided
adequate description of execution of index test (100%) and
reference tests (100%). The majority of articles used an adequate
reference standard (97%). The majority also had absence of
disease progression bias (97%) and absence of partial verification
bias (94%). Potential for differential verification bias (91%) and
selection bias (88%) was minimal. Five quality items were
addressed in 60% of papers or less; absence of clinical review
bias (45%), report of un-interpretable results (33%), absence of
index test review bias (36%), absence of reference test review bias
(24%), and description of withdrawals (21%). A limiting factor in
assessing methodological quality was unclear reporting by authors.
Absence of reference and index test review bias was unclear in
76% and 61% of articles respectively. Absence of clinical review
bias was unclear in 51% of articles.
Quality of reporting of studies was assessed using the STARD
checklist. These results are presented in Table S3. Only 4 of the 25
items were reported by all the articles. Of these, three items (items
7–9) were under methods; reference standard used and its
rationale (100%), technical specifications of materials and methods
(100%), definition of and rationale for units, and the clinical
applicability of findings (100%). Items 5, 11, 13, 17, 20, 22, 23,
and 24 were reported by 50% of articles or less, with item 20
(report of any adverse effects from use of index test or reference
standard) being the least reported item (3%). About 33% (11/33)
of papers reported on conflicts of interest, with each having at least
one conflict of interest. In four articles [16–18], the authors
evaluated the diagnostic test they had manufactured themselves or
contributed to its manufacturing. The role of conflict of interest as
a predictor of diagnostic performance could not be explored.
Discussion
Using a TP specific reference standard in serum, the Determine
rapid test had the best estimate for sensitivity and Syphicheck had
the best specificity. Overall, rapid and POC tests performed well in
both sensitivity and specificity compared to laboratory-based TP
specific tests such as TPPA and TPHA that have sensitivity in the
range of 85–100% and specificity in the range of 98–100% [5]. In
this meta-analysis, correcting for imperfect reference standards
improved the accuracy estimates of all rapid and POC tests. In all
comparisons, estimates in serum were higher than estimates in
whole blood. This was expected because of high concentration of
biomarkers in serum and the absence of interfering substances in
whole blood. It should be noted that meta-analysis results from the
whole blood group assuming an imperfect TP specific reference
standard are most relevant to decision makers as they best capture
circumstances most encountered in resource constrained settings.
There are limitations to the use of rapid and POC syphilis tests
that arise from the inherent characteristics of the tests. The rapid
and POC tests analyzed in this review are treponemal tests and
thus detect antibodies to T. pallidum. As previously mentioned,
treponemal tests cannot be used to distinguish between active and
past infection as antibodies to T. pallidum persist even if the patient
is successfully treated [6]. In resource limited settings, these tests
have been shown to be useful in detecting infection in patients with
no previous access to testing or at risk populations marginalised
from care or unlikely to return for results, and where failure in
timely treatment can have adverse impacts on disease progression
and transmission [5,6,8].
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Table 1. Results of pooled sensitivity and specificity, before and after adjustment for imperfect reference standard.
POC Test Sample
Reference
Standard Pooled Parameters
Assuming Perfect
Reference Standard
(95% CrI)
Assuming
Imperfect Reference
Standard (95% CrI)
Reported Parameter
by Manufacturer
Determine Serum TP Specific (n = 11) Sensitivity 92.03% (87.22, 95.77) 90.04% (80.45, 95.21) 100%
Specificity 92.68% (87.24, 95.87) 94.15% (89.26, 97.66) 100%
Whole Blood TP Specific (n = 15) Sensitivity 79.54% (71.95, 86.04) 86.32% (77.26, 91.70) 92.30%
Specificity 98.91% (97.71,99.71) 95.85% (92.42, 97.74) 100%
TP & non-TP Specific
(n = 8)
Sensitivity 77.68% (60.94, 90.40) 47.84% (18.25, 83.18) NA
Specificity 98.18% (94.42, 99.93) 97.81% (89.75, 99.79) NA
SD Bioline Serum TP Specific (n = 8) Sensitivity 87.88% (82.43, 91.80) 87.06% (75.67, 94.50) 99.3%
Specificity 96.03% (92.67, 98.05) 95.85% (89.89, 99.53) 99.5%
Whole Blood TP Specific (n = 13) Sensitivity 83.78% (80.89, 86.47) 84.50% (78.81, 92.61) NA
Specificity 98.39% (97.56, 99.01) 97.95% (92.54, 99.33) NA
Syphicheck Serum TP Specific (n = 7) Sensitivity 75.96% (63.55, 85.29) 74.48% (56.85, 88.44) 100%
Specificity 98.51% (96.85, 99.59) 99.14% (96.37, 100.0) NA
Whole Blood TP Specific (n = 12) Sensitivity 75.12% (70.00,80.48) 74.47% (63.94, 82.13) NA
Specificity 99.44% (98.96, 99.81) 99.58% (98.91, 99.96) NA
Visitect Serum TP Specific (n = 7) Sensitivity 87.32% (79.97, 92.14) 85.13% (72.83, 92.57) NA
Specificity 95.76% (92.17, 97.76) 96.45% (91.92, 99.29) NA
Whole Blood TP Specific (n = 14) Sensitivity 76.22% (69.82, 81.62) 74.26% (53.62, 83.68) NA
Specificity 99.33% (98.73, 99.78) 99.43% (98.22, 99.98) NA
CrI = Credible Interval; ‘‘n’’ refers to the number of data entries per group; NA=Not Available.
doi:10.1371/journal.pone.0054695.t001
Table 2. Results of sensitivity analysis.
POC Test Sample Reference Standard
Pooled
Parameters
5% Widened Priors
(95% CrI)*
10% Widened Priors
(95% CrI)*
15% Widened Priors
(95% CrI)*
Determine Serum TP Specific (n = 11)** Sensitivity 90.11% (84.62, 94.48) 90.50% (84.70, 94.78) 88.89% (78.82, 96.25)
Specificity 94.23% (90.07, 97.18) 93.97% (89.51, 97.26) 93.12% (85.21, 97.69)
Whole Blood TP Specific (n = 15) Sensitivity 78.40% (69.72 85.50) 77.78% (67.66, 86.05) 78.23% (66.79, 87.21)
Specificity 99.07% (97.92, 99.81) 99.01% (97.78, 99.77) 98.97% (97.10, 99.86)
TP & non-TP Specific
(n = 8)
Sensitivity 45.07% (16.10, 75.05) 62.35% (38.67, 85.64) 76.78% (58.80, 90.17)
Specificity 98.83% (89.91, 99.98) 99.20% (96.24, 99.99) 98.48% (94.01, 99.98)
SD Bioline Serum TP Specific (n = 8) Sensitivity 88.91% (81.06, 94.11) 88.57% (80.70, 93.88) 88.34% (80.01, 94.46)
Specificity 94.77% (89.22, 98.72) 95.06% (90.12, 98.69) 95.17% (89.13, 98.83)
Whole Blood TP Specific (n = 13) Sensitivity 77.45% (61.91, 87.52) 80.16% (58.30, 96.79) 82.60% (72.64, 88.70)
Specificity 97.88% (94.74, 99.87) 97.90% (89.52, 99.98) 98.20% (96.61, 99.66)
Syphicheck Serum TP Specific (n = 7) Sensitivity 61.14% (35.02, 82.86) 72.68% (50.60, 90.73) 71.45% (43.99, 91.00)
Specificity 98.28% (92.36, 99.98) 98.99% (93.79, 100.0) 99.16% (94.42, 100.0)
Whole Blood TP Specific (n = 12) Sensitivity 74.31% (62.03, 83.53) 74.56% (60.21, 83.11) 63.64% (45.56, 81.40)
Specificity 99.54% (98.68, 99.99) 99.53% (98.68, 99.98) 99.20% (97.13, 99.98)
Visitect Serum TP Specific (n = 7) Sensitivity 87.03% (77.00, 94.41) 85.46% (72.42, 93.92) 81.56% (64.86, 92.33)
Specificity 95.64% (88.72, 99.15) 96.20% (90.32, 99.59) 95.63% (87.93, 99.35)
Whole Blood TP Specific (n = 14) Sensitivity 73.10% (55.41, 84.13) 75.04% (57.52, 85.07) 76.34% (67.10, 83.98)
Specificity 99.35% (97.58, 99.99) 99.41% (98.20, 99.98) 99.37% (98.40, 99.89)
CrI = Credible Interval; ‘‘n’’ refers to the number of data entries per group.
doi:10.1371/journal.pone.0054695.t002
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In a study conducted in Brazil, Mabey et al. [8] found rapid and
POC tests to be helpful in the Amazonas region, a remote location
where no testing was previously possible. In the case of syphilis,
rapid and POC tests can easily facilitate initiation of treatment and
prevention of transmission and reduce the reservoir of infection in
the community. Following a positive result with a rapid and POC
test, a first dose of penicillin is recommended to be administered
on the same day [8]. In pregnant women, a single dose of
penicillin before the third trimester is adequate to prevent neonatal
deaths and stillbirths [8]. Watson-Jones et al. [19] found that the
rate of adverse pregnancy outcome is similar in pregnant women
treated with single-dose penicillin before the end of the second
trimester compared to those seronegative for syphilis. Considering
the adverse outcomes associated with maternal syphilis as well as
chances of onward transmission to partners, the benefit of
screening using rapid and POC tests far outweighs the risk of a
small proportion of missed cases due to false negative results or
over-treatment due to a past infection in resource limited settings..
Improvements in accuracy parameters that reduce the occur-
rence of false positives and false negatives as well as addition of
non-TP components to rapid and POC tests are warranted, but
waiting for a ‘‘perfect test’’ will mean that over 500,000 babies
could be stillborn or die of congenital syphilis every year [8].
Three studies and models have clearly demonstrated a positive
impact of using these less than perfect rapid and POC tests on
reducing the disease burden of syphilis in resource limited settings.
Aledort et al. [20] described a model, funded by the Bill &
Melinda Gates Foundation, that showed that a diagnostic test for
antenatal syphilis screening that meets the performance of the
current laboratory-based RPR test (86% sensitivity and 72%
specificity), but requires no infrastructure, and assuming a 100%
treatment rate, would save more than 201,000 lives and avert
215,000 stillbirths. In the model, the positive outcomes of using
such a test are more dependent on effective diagnoses and
treatment rather than inappropriate treatment, as treatment has
generally low harm [20]. Penicillin has rarely any side effects when
given at the therapeutic doses [21,22], there is no evidence that T.
pallidum has developed resistance to penicillin [5], and it is
inexpensive [23]. The rapid and POC tests in this meta-analysis
fulfilled the performance threshold in the model and can hence be
recommended to save lives in resource limited settings. In another
study, conducted by Vickerman et al. [24], potential benefits of
rapid and POC tests instead of RPR were modeled. Results
showed that rapid and POC tests led to a higher treatment rate
than RPR. In a study by Bronzan et al. [25] in rural South Africa,
rapid and POC tests, in comparison to other methods, resulted in
the highest percentage of pregnant women correctly diagnosed
and treated for syphilis (89.4% for rapid tests, 63.9% for on-site
RPR, 60.8% for offsite RPR/TPHA). The on-site RPR had low
sensitivity (71.4% for high-titer syphilis) while the offsite approach
suffered from poor client return rates. One percent of women
screened with the rapid and POC tests may have received
penicillin unnecessarily but there were no adverse treatment
outcomes [25]. These studies serve to show that rapid and POC
tests can reduce syphilis-related adverse outcomes of pregnancy
through timely diagnosis and immediate treatment of pregnant
women with syphilis.
In this meta-analysis, the POC tests evaluated are TP –specific
tests and as such, they were compared to TP-specific reference
tests. The goal was to determine their accuracy as a screening tool,
which in an ideal setting, will be used in an algorithm with other
tests such as non-TP specific tests to diagnose syphilis. Non-TP
antibodies are generally a better indicator of active syphilis
infection as the antibodies decline after treatment. However, non-
TP tests measure anti-cardiolipin antibodies, which can give rise to
false positive due to presence of factors such as malaria, immune
disorders, and pregnancy.
In Watson-Jones’s study from Tanzania, as many as 27.5% of
RPR positive results in pregnant women could not be confirmed
by the Treponema pallidum Particle Agglutination (TPPA) assay [19].
In addition, Creegan et al. found that non-TP tests were less
sensitive than TP tests in detecting early syphilis [26].
This meta-analysis is concerned with the use of these rapid POC
tests in resource limited settings where laboratory infrastructures are
limited or non-existent. In 2004, Schmid et al. reported that in
developing countries, an estimated 68% of urban women and 39% of
rural women access antenatal care [27]. Universal institution of an
effective programme for syphilis screening and treating those who are
seropositive would avoid 492,000 deaths in Africa alone. Screening
rates remain very low in most rural settings. However, rapid and POC
tests, despite their imperfect performance, have already been shown in
large implementation pilot studies to have averted many deaths [8].
A great step forward is the new rapid and POC tests that
simultaneously detect TP and non TP specific antibodies such as the
assay evaluated by Castro et al. [16,28]. Such tests provide a clear
advantage over tests that only detect TP antibodies by helping to
distinguish between past and current infections. However, as of this
year, there was limited published data in this regard to allow for
exploration of their accuracy. More research on these combination
tests is highly warranted. These tests will certainly help expedite
screening and referral for treatment in the years to come.
This is the first meta-analysis providing a comparison of the
diagnostic accuracy of popular rapid and POC tests for syphilis. In a
previous review conducted by Tucker et al. [9], data were analyzed
using a standard meta-analysis method that does not adjust for the
imperfections of reference standards. In this review, adjustments were
made for imperfect reference standards using Bayesian HSROC
method, literature were explored in all languages, and quality of
evidence was rated with validated checklists. The accuracy of rapid and
POC syphilis tests was estimated by examining the global evidence and
analyzing results by indivdual tests, sample and reference standards,
thus prodviding evidence useful for policy and planning. Additionally,
implementation research outcomes such as acceptability, feasibility and
economic outcomes were synthesized in a separate review by the
authors of this article [29].
Limitations
This meta-analysis is subject to limitations that should be borne
in mind while interpreting results. Although a comprehensive
search strategy was implemented, it is possible that relevant studies
may have been missed, thus there is potential for publication bias.
There is also a possibility that studies that showed higher accuracy
are published more favorably. However, exploration of publica-
tion bias with funnel plots is not recommended in meta-analyses
and was not carried out [14]. As well, the reviewers were un-
blinded to the authors and institutions that may potentially
introduce detection bias [12].
There are limitations to the statistical analysis conducted. Prior
distributions used for the HSROC analysis assuming imperfect
reference standard were obtained from literature and themselves
measured against other TP and non-TP specific tests. As a result,
there is no guarantee that these ranges are correct. Hence,
interpretations of Bayesian inferences must be made conditional
on choice of priors. Thus, the analysis was limited by the current
methodology of diagnostic accuracy meta-analyses.
Moreover, lack of data limited further analysis. There is a visible
time trend in this review, with studies spanning almost two
decades. There have been many improvements in conjugates and
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test devices during this period. However, with limitations in data
from various settings and type of devices, it was not possible to sort
the data by years and evaluate the trajectory of improving
diagnostic accuracy over time. Lack of data also did not allow for
further stratification in order to investigate the effect of using
various samples, such as whole blood obtained from fingerstick or
venipuncture which is treated with anti-coagulants. Exploration of
accuracy of rapid and POC tests by stage of infection and status of
co-infections was hindered by lack of available data. Future studies
may need to explore the accuracy of rapid and POC tests by stage
and by co-infection status in greater detail, particularly in the light
of integrated multiplexed screening initiatives for several STIs that
are under development. Due to lack of data availability, analysis
was largely generated using treponemal tests, which overestimate
sensitivity of detecting acute, untreated disease [30].
There were limitations due to poor methodology and reporting in
the publications. A low number of studies (33%) reported on conflicts of
interest and only 24% reported on whether the study was conducted
blindly, raising the possibility of detection bias. Journals should
promote greater standards of reporting in order to promote
transparency. Barring these caveats, popular rapid and POC tests
were compared in various samples to obtain an assessment of their
global accuracy to inform evidence based decision making for policy
initiatives.
Conclusion
This meta-analysis found that rapid and POC treponemal tests had
high sensitivity and specificity in serum and blood that was at par or
better than laboratory-based non-treponemal tests currently in use in
most resource limited settings. Despite being less than 100% accurate,
in areas where there is no access to laboratory screening facilities for
syphilis, rapid and POC tests have the potential to facilitate rapid
improved detection of syphilis, allowing for treatment initiation in the
same visit, reducing missed opportunities for detection and timely
intervention to prevent transmission to infants and to partners. Based
on the evidence, it is concluded that rapid and POC tests are useful in
global settings with limited access to laboratories or screening for
syphilis. The duplex rapid TP- non-TP rapid and POC test as well as
improvements in sensitivity will prevent over diagnosis and over
treatment of syphilis in these settings.
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